title: Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells.
abstract: Plasma low- and high-density lipoproteins (LDL and HDL) are cleared from the circulation by specific receptors and are either totally degraded or their cholesteryl esters (CE) are selectively delivered to cells by receptors such as the scavenger receptor class B type I (SR-BI). The aim of the present study was to define the effect of apoC-II and apoC-III on the uptake of LDL and HDL by HepG2 cells. Stable transformants were obtained with sense or antisense strategies that secrete 47-294% the normal level of apoC-II or 60-200% that of apoC-III. Different levels of secreted apoC-II or apoC-III had little effect on LDL and HDL protein degradation by HepG2 cells. However, compared to controls, cells under-expressing apoC-II showed a 160% higher capacity to selectively take up HDL-CE, while cells under-expressing apoC-III demonstrated 70 and 160% higher capacity to take up CE from LDL and HDL, respectively. In experiments conducted with exogenously added apoC-II or apoC-III, no significant effect was observed on lipoprotein-protein association/degradation; however, LDL-CE and HDL-CE selective uptake was significantly reduced in a dose-dependent manner. These results indicate that apoC-II and apoC-III inhibit CE-selective uptake.
authors.affiliation: Département des Sciences Biologiques, Université du Québec à Montréal, C.P. 8888, Succ. Centre-ville, Montréal, Que., Canada H3C 3P8.
authors.forename: Karine
authors.initials: K
authors.lastname: Huard
authors.forename: Philippe
authors.initials: P
authors.lastname: Bourgeois
authors.forename: David
authors.initials: D
authors.lastname: Rhainds
authors.forename: Louise
authors.initials: L
authors.lastname: Falstrault
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Cohn
authors.forename: Louise
authors.initials: L
authors.lastname: Brissette
mesh_terms: D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C / Q000378:metabolism / Q000502:physiology*; D018955:CD36 Antigens; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D045744:Cell Line, Tumor; D008076:Cholesterol, HDL / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D006801:Humans; D011971:Receptors, Immunologic / Q000378:metabolism; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B
chemical_list: D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C; D018955:CD36 Antigens; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; C495124:SCARB1 protein, human; D051122:Scavenger Receptors, Class B